Alkòl

Xylazine, a veterinary sedative that is NOT approved for use in humans, is a growing threat in the United States. Xylazine is often mixed with fentanyl, heroin, cocaine or other drugs to increase their potency, but it can also be sold on its own as a recreational drug called “Tranq”. The deadly combination of fentanyl and xylazine has contributed to a surge of overdose deaths in recent years. In fact, Xylazine was involved in 10% of Connecticut overdose deaths in 2020, and presence of the drug in DEA tested samples has increased by 62% in the Northeast from 2020-2021. It is possible that the prevalence of Xylazine in illicit drug combinations and its involvement in fatal overdoses may be higher than currently reported.

Users report that Xylazine can produce opioid-like effects. It can cause depression of the central nervous system, along with other harmful effects such as respiratory depression, seizures, and even death. Unlike fentanyl, xylazine is resistant to treatment with naloxone to reverse overdose. This makes overdose all the more dangerous, as it increases the risk of death significantly. 

Overall, IMPDs, fentanyl, and xylazine are highly dangerous drugs with serious health consequences that include addiction and increased risk of overdose deaths. Seeking professional help is crucial for individuals struggling with the use of Illicitly Manufactured Prescription Drugs. Recovery options are available to facilitate recovery and lead fulfilling lives.